Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
about
Pharmacological therapy used in the elimination of Helicobacter pylori infection: a reviewTreatment of Helicobacter pylori infection 2011.Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensusEfficacy of levofloxacin and rifaximin based quadruple therapy in Helicobacter pylori associated gastroduodenal disease: a double-blind, randomized controlled trial.Prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infectionHigh efficacy of gemifloxacin-containing therapy in Helicobacter Pylori eradication: A pilot empirical second-line rescue therapy.Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial.3rd Brazilian Consensus on Helicobacter pylori.Levofloxacin-based first-line therapy versus standard first-line therapy for Helicobacter pylori eradication: meta-analysis of randomized controlled trials.Is levofloxacin-based triple therapy an alternative for first-line eradication of Helicobacter pylori? A systematic review and meta-analysis.Levofloxacin and proton pump inhibitor-based triple therapy versus standard triple first-line therapy for Helicobacter pylori eradication.Fluoroquinolone-based protocols for eradication of Helicobacter pyloriHelicobacter pylori treatment: Still a work in progress.Update on triple therapy for eradication of Helicobacter pylori: current status of the artA new paradigm for clinical trials in antibiotherapy?
P2860
Q28085016-D0E083C4-9CE7-465F-8453-1F0B23DB6638Q34028419-246B5FE0-4C4B-4D98-9194-0844D9E91770Q34067951-8BD9051F-7CCF-4E99-A2F4-03CA6D7A3165Q35009862-F8D85571-F9E4-4C82-9E6C-1350962BC74EQ35973782-219A4FA0-DC26-4C73-B10C-93063A245207Q37364909-225BB43C-4F5B-4441-A73A-193C9A1888E1Q37656247-5E74CFA7-AA9E-4D5B-BDDC-2F0602807C8EQ38113105-9C3762AF-D9E1-4CCE-904D-D9DAF16029EFQ38182087-09A90EFA-CD22-4E1C-A456-18E69EA3C046Q38194611-13A1C2DC-B1CC-4D1B-882C-E93C4A513F60Q38200052-1C151021-FB33-4D34-83D0-ECA8840F7C93Q38235943-63506044-1E44-4C1A-915E-DABB25E3CCCAQ38613590-2FC8EBE6-E692-4A8D-B034-C9E32AD11314Q42094393-DEDDC48F-633F-448A-8CDF-FEC6D0B5199EQ42838869-3A7B9182-FEEF-49A2-9AAB-B65BE2024E98
P2860
Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Efficacy and safety of Levoflo ...... omparative, multicenter study.
@en
Efficacy and safety of Levoflo ...... omparative, multicenter study.
@nl
type
label
Efficacy and safety of Levoflo ...... omparative, multicenter study.
@en
Efficacy and safety of Levoflo ...... omparative, multicenter study.
@nl
prefLabel
Efficacy and safety of Levoflo ...... omparative, multicenter study.
@en
Efficacy and safety of Levoflo ...... omparative, multicenter study.
@nl
P2093
P1476
Efficacy and safety of Levoflo ...... omparative, multicenter study.
@en
P2093
M Abdel Rasheed
M Abdelfatah
M Shastery
P304
P356
10.1016/J.EJIM.2010.05.011
P577
2010-06-16T00:00:00Z